About PharmaFluidics
PharmaFluidics is a company based in Ghent (Belgium) founded in 2010 was acquired by Thermo Fisher Scientific in November 2021. The company has 14 employees as of December 31, 2021. PharmaFluidics operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
- Headquarter Ghent, Belgium
- Employees 14 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmafluidics Nv
-
Annual Revenue
$842.5 K (USD)253as on Dec 31, 2019
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Thermo Fisher Scientific
& 6 more
-
Employee Count
14
as on Dec 31, 2021
-
Acquired by
Thermo Fisher Scientific
(Nov 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PharmaFluidics
Investors in PharmaFluidics
PharmaFluidics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, PMV and SFPIM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity is directed toward private and public companies.
|
Locked | Locked | Locked | |
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital fund investing in technological breakthroughs from universities.
|
Locked | Locked | Locked |
Investor details for PharmaFluidics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaFluidics
Investment portfolio details for PharmaFluidics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PharmaFluidics
Detailed financials for PharmaFluidics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmafluidics Comparisons
Peer comparison for PharmaFluidics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmaFluidics
PharmaFluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of proprietary filtration solutions for life science
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
Detailed competitors of PharmaFluidics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmafluidics
Complete news archive for PharmaFluidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaFluidics
PharmaFluidics was founded in 2010 and raised its 1st funding round 4 years after it was founded.
PharmaFluidics is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
As of Dec 31, 2021, the latest employee count at PharmaFluidics is 14.
Annual revenue of PharmaFluidics is $842.5K as on Dec 31, 2019.
PharmaFluidics was founded in 2010 in Ghent, Belgium, and operates within the life sciences sector focused on chromatography tools. Proprietary µPAC cartridges are provided as plug-and-play solutions for analyzing trace compounds in complex mixtures and detecting modifications in biological molecules. These cartridges, produced via lithographic micromachining, support biomarker research with controlled flow rates, enhanced resolution, and improved repeatability in standard nano-LC systems.
PharmaFluidics's top competitors include ChromaTan, Sepragen and Sepax Technologies.
PharmaFluidics has 7 investors. Key investors include Thermo Fisher Scientific, PMV, SFPIM, Qbic Venture Partners, and Theodorus.